GlassScriptPhysician profile
Kenneth H Eckhert
NPI 1427026327
$10,640.39
in general payments reported to CMS, 2019-2025
29 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,937 · 2020: $173 · 2021: $255 · 2022: $278 · 2023: $500 · 2024: $387 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $5,364.68 | 2019-2022 | |
| Intuitive Surgical, INC. | $2,967.02 | 2019-2024 | |
| Endogastric Solutions, INC | $725.70 | 2019-2024 | Esophyx |
| Tela Bio, INC. | $198.51 | 2019-2024 | Ovitex 2s |
| Covidien LP | $149.29 | 2019 | |
| Medtronic, INC. | $144.20 | 2021-2025 | Progrip, Rapidvac, Ligasure |
| Smith+Nephew, INC. | $130.04 | 2019-2023 | Collagenase Santyl, Oasis Micro, Oasis |
| W. L. Gore & Associates, INC. | $124.16 | 2019 | |
| Conmed Corporation | $109.20 | 2019 | |
| Medical Device Business Services, INC. | $89.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.53 | 2021 | |
| Abbott Laboratories | $60.79 | 2019 | |
| Baxter Healthcare | $59.73 | 2021-2022 | |
| Integra Lifesciences Corporation | $47.23 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kowa Pharmaceuticals America, INC. | $43.27 | 2023 | Seglentis |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $42.45 | 2025 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $38.00 | 2024 | Bridion |
| Solventum Corporation | $35.41 | 2024 | Activ.A.C. |
| Kci USA, INC. | $34.00 | 2021-2023 | Activ.A.C. |
| Shire North American Group INC | $33.86 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $29.73 | 2019-2020 | |
| Pfizer INC. | $22.84 | 2024 | |
| Avanos Medical | $20.12 | 2021 | |
| Aroa Biosurgery Incorporated | $19.34 | 2025 | |
| Boston Scientific Corporation | $18.70 | 2024 | Spyglass Discover |
| Mesh Suture INC | $17.83 | 2024 | |
| Teleflex LLC | $16.69 | 2024 | Deknatel |
| Pacira Pharmaceuticals Incorporated | $16.24 | 2023 | Exparel |
| Kerecis Limited | $15.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Eckhert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.